Shares of IMS Health Holdings Inc. (NYSE:IMS) shot up 2.8% on Thursday . The stock traded as high as $28.31 and last traded at $28.30, with a volume of 1,455,565 shares changing hands. The stock had previously closed at $27.53.

Several research firms have weighed in on IMS. Zacks Investment Research lowered IMS Health Holdings from a “hold” rating to a “sell” rating in a report on Tuesday. Topeka Capital Markets upped their target price on IMS Health Holdings from $29.00 to $30.00 and gave the company a “buy” rating in a report on Wednesday, May 4th. Piper Jaffray Cos. reissued an “overweight” rating and issued a $32.00 target price (up previously from $28.00) on shares of IMS Health Holdings in a report on Thursday, March 24th. Finally, Wells Fargo & Co. lowered IMS Health Holdings from an “outperform” rating to a “market perform” rating in a report on Thursday, May 12th. One equities research analyst has rated the stock with a sell rating, two have given a hold rating and six have assigned a buy rating to the company. IMS Health Holdings currently has a consensus rating of “Buy” and a consensus price target of $31.22.

The firm has a 50-day moving average of $25.77 and a 200-day moving average of $25.37. The firm has a market cap of $9.34 billion and a PE ratio of 58.11.

IMS Health Holdings (NYSE:IMS) last announced its quarterly earnings results on Tuesday, May 3rd. The company reported $0.42 earnings per share for the quarter, topping analysts’ consensus estimates of $0.38 by $0.04. During the same period in the prior year, the firm earned $0.39 EPS. The company earned $774 million during the quarter, compared to analyst estimates of $749.34 million. IMS Health Holdings’s quarterly revenue was up 22.5% on a year-over-year basis. Analysts predict that IMS Health Holdings Inc. will post $1.60 EPS for the current fiscal year.

Several hedge funds recently made changes to their positions in the company. Korea Investment CORP bought a new stake in shares of IMS Health Holdings during the fourth quarter worth $1,077,000. Deimos Asset Management LLC bought a new stake in shares of IMS Health Holdings during the fourth quarter worth $1,296,000. Gulf International Bank UK Ltd bought a new stake in shares of IMS Health Holdings during the fourth quarter worth $1,338,000. Cornerstone Capital Management Holdings LLC. bought a new stake in shares of IMS Health Holdings during the fourth quarter worth $1,430,000. Finally, Oxford Asset Management bought a new stake in shares of IMS Health Holdings during the fourth quarter worth $1,574,000.

IMS Health Holdings, Inc (IMS) is an information and technology services company that provides solutions to its clients in the healthcare industry. The Company has its presence in over 100 countries. The Company’s data set contains over 10 petabytes of data and over 500 million patient records. It serves healthcare organizations and life science companies, including pharmaceutical, biotechnology, consumer health and medical device manufacturers, as well as distributors, providers, payers, government agencies, policymakers, researchers and the financial community.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.